Efficacy and Safety of Eliapixant in Refractory Chronic Cough: The Randomized, Placebo-Controlled Phase 2b PAGANINI Study
Peter V. Dicpinigaitis, Alyn H. Morice, John A. Smith, Mandel Sher, Michael F. Vaezi, Laurent Guilleminault, Akio Niimi, Kerstin Gude, Ulrike Krahn, Riitta Saarinen, Philippe Vieira Pires, Melanie Wosnitza, Lorcan McGarvey, the PAGANINI Investigators
Topics & Concepts
MedicinePlaceboDysgeusiaDiscontinuationTolerabilityClinical endpointAdverse effectInternal medicineRandomized controlled trialRefractory (planetary science)GastroenterologyPathologyAstrobiologyPhysicsAlternative medicineRespiratory and Cough-Related ResearchChronic Obstructive Pulmonary Disease (COPD) ResearchPediatric health and respiratory diseases